Ivan Horbachevsky Ternopil National Medical University or simply Ternopil National Medical University is a government university run by the Ministry of Health as well as a medical university located in the city of Ternopil in Ukraine.

During the past decade, Ternopil University Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ternopil University Hospital" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Abivax S.A." with 2 trials sponsored, "Allergan" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ternopil University Hospital" #1 collaborator was "Academic Medical Organization of Southwestern Ontario" with 1 trials as a collaborator and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ternopil University Hospital" are "Ulcerative Colitis" (3 trials), "Crohn's Disease" (2 trials), "Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Ternopil University Hospital" in a lesser frequency.

Most popular intervention types in "Ternopil University Hospital" are "Drug" (16 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "filgotinib" (3 trials), "GDC-0853" (2 trials), "Placebo Oral Tablet" (2 trials) and "Relamorelin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ternopil University Hospital" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Ternopil University Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ternopil University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ternopil University Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Ternopil University Hospital has several departments that took part in Clinical trials: "Ternopil RCCPH Depts of Psychiatry #2 (m) & Psychiatry #4 (f) Ternopil I.Ya. Gorbachevskyi SMU" - 5 trials